Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Planning for retirement now can significantly enhance your financial security. Learn the reasons to prioritize your retirement planning today.
27,829 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Alix Earle launches Reale Actives, a skincare line built for acne-prone skin, marking her move from viral creator to ...
New Hampshire lawmakers pivot from a sweeping pro-housing mandate to targeted reforms after local pushback. HB1010 mo...
A wave of budget-conscious shoppers is steering growth at discount grocers, reshaping grocery traffic and profits. An...
NextHome opens two Southern California offices, extending its coastal footprint with about 200 agents under a revampe...
From classroom grades to a billion-dollar chicken brand, Raising Cane’s growth highlights the power—and perils—of a s...
Google and Blackstone are teaming up to back a $5 billion Newcloud venture built around TPU chips, aiming to outpace ...
Grab is moving to pilot a new delivery robot in Singapore’s Punggol district by late 2026, aiming to relieve labor sh...
Class Valuation partners with Makena to roll out InstaPlan to its appraisers ahead of the UAD 3.6 deadline, aiming to...
The Social Security Administration’s new commissioner argues that wait times are down and more people are being serve...
A century of uninterrupted payouts makes this historic dividend stock hand a rare anchor for investors navigating vol...
A hedge-fund short report rattled Bloom Energy, triggering a brief stock drop before a swift rebound. Investors are w...